DOW JONES21,052.53-360.91 -1.69%
S&P 5002,488.65-38.25 -1.51%
NASDAQ7,373.08-114.23 -1.53%

Goldman Sachs Downgrades Calyxt to Neutral, Lowers Price Target to $7

Goldman Sachs analyst Adam Samuelson downgrades Calyxt (NASDAQ:CLXT) from Buy to Neutral and lowers the price target from $19 to $7.

Benzinga · 03/06/2020 09:50

Goldman Sachs analyst Adam Samuelson downgrades Calyxt (NASDAQ:CLXT) from Buy to Neutral and lowers the price target from $19 to $7.